Skip to content

Effect of oral minoxidil in treatment of lichen planopilaris

Evaluation of the effect of adding oral minoxidil to standard anti-inflammatory therapy in the treatment of patients with lichen planopilaris

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220528055005N1
Enrollment
34
Registered
2022-06-03
Start date
2022-06-22
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planopilaris. Follicular Lichen Planus

Interventions

Intervention 1: Intervention group: Methotrexate ( 15 mg/week orally in one day) will be administered in one group ( 17 patients) and for 6 months. Intervention 2: Intervention group: Minoxidil 1 mg t

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed patients who have not yet received treatment. Patients who have previously been treated and whose disease is still active according to clinical and dermoscopic criteria Patients should have discontinued any previous systemic medication 1 month before entering the study and should not use any systemic or topical medication at the time of the study

Exclusion criteria

Exclusion criteria: pregnancy or breastfeeding Leukocytes <3000 Platelets <100000 Hemoglobin <9 Liver enzymes more than 2 times the reference limit Positive for viral hepatitis tests History of cardiovascular disease and hypotension History of arrhythmia (non-sinus rhythm on ECG)

Design outcomes

Primary

MeasureTime frame
Lichen planopilaris activity index. Timepoint: Befor and after intervention. Method of measurement: Cheklist.;Standardized global photography. Timepoint: Befor and after intervention. Method of measurement: Based on scoring by two dermatologist.;Dermoscopy. Timepoint: Befor and after intervention. Method of measurement: Chcklist.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shaghayegh dehghani

Esfahan University of Medical Sciences

sh_dehghanii@yahoo.com+98 31 3668 8644

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026